ANGIONAUTIX REACHES AGREEMENT WITH GALAXY THERAPEUTICS TO DISTRIBUTE SEAL

READ MORE

ANGIONAUTIX REACHES AN AGREEMENT WITH ELEVATE SCIENTIFIC TO DISTRIBUTE ABSOLUTE GEL IN SPAIN AND PORTUGAL

READ MORE
La próxima generación de recubrimiento antitrombogénico

HEAL TECHNOLOGY: THE NEXT GENERATION OF ANTITHROMBOGENIC COATING

READ MORE

The first 209 patients were analyzed, with a 72.7% FPE result

READ MORE

Neurovascular

division

See more

Cardiovascular

division

See more

Healthcare

Applications

See more

PATHOLOGIES

1
2
3
4
5
6
7
8
NEUROVASCULAR PATHOLOGIES
CARDIOVASCULAR PATHOLOGIES
NEUROVASCULAR PATHOLOGIES
CARDIOVASCULAR PATHOLOGIES

Last news

Angionautix reaches agreement with Galaxy Therapeutics to distribute SEAL

SEAL is an intrasaccular device for the treatment of intracranial aneurysms. It will now be able to benefit hundreds of patients in our country.

Angionautix reaches an agreement with Elevate Scientific to distribute Absolute Gel in Spain and Portugal.

Absolute Gel functions as a flexible implant for the treatment of disc herniation (one of the most common causes of chronic back pain) through a minimally invasive percutaneous procedure. From now on, it will benefit thousands of patients in our region.
la próxima generación de recubrimiento antitrombogénico

HEAL Technology: The next generation of antithrombogenic coating

The HEAL Technology mimics the final step of natural haemostasis and thus the conversion of fibrinogen (by thrombin) to fibrin.

Our brands

 
PreviousNext
12